Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Unecritinib (TQ-B3101) is a potent, orally active, highly potent, blood-brain barrier permeable and low toxic inhibitor of EGFR tyrosine kinase with antitumor activity. Unecritinib inhibited ALK, ROS1 and MET. Unecritinib is a potential compound for the study of solid tumors and relapsed or refractory AlK-positive anaplastic large cell lymphomas.
Description | Unecritinib (TQ-B3101) is a potent, orally active, highly potent, blood-brain barrier permeable and low toxic inhibitor of EGFR tyrosine kinase with antitumor activity. Unecritinib inhibited ALK, ROS1 and MET. Unecritinib is a potential compound for the study of solid tumors and relapsed or refractory AlK-positive anaplastic large cell lymphomas. |
Synonyms | TQ-B3101 |
Molecular Weight | 492.37 |
Formula | C23H24Cl2FN5O2 |
CAS No. | 1418026-92-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 90.0 mg/mL (182.8 mM), ultrasonic and warming and heat to 60°C
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Unecritinib 1418026-92-2 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR c-Met/HGFR ALK ROS Kinase TQ-B3101 Inhibitor inhibitor inhibit